Taylor
Novo Nordisk unveils plans for $100m API plant
March 17, 2014Manufacturing and Production API, FDA, Novo Nordisk, Taylor, copenhagen
Novo Nordisk says it will invest around $100m in a new pilot facility to make the active pharmaceutical ingredients (APIs) …
UK cancer death rate could be halved by 2030
January 10, 2014Research and Development, Sales and Marketing Cancer, Taylor, UCL, wardle
British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …
FDA and EMA team up for generic drug inspections
January 6, 2014Manufacturing and Production EMA, FDA, GMP, Taylor, manufacturing
The regulatory authorities in the US and EU have taken another step towards harmonisation by agreeing to pool their resources …
GSK funnels another £200m into UK manufacturing
December 12, 2013Manufacturing and Production, Sales and Marketing GSK, Taylor, UK, manufacturing
GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …
FDA seeks top-to-toe review of Wockhardt manufacturing
December 9, 2013Manufacturing and Production AZ, GMP, Taylor, Wockhardt. fda
Wockhardt has been asked to undertake an assessment of its entire manufacturing processes, according to an FDA warning letter. Sent …
Pfizer cuts manufacturing again with plant closure
December 9, 2013Manufacturing and Production Ireland, Merck, Pfizer, Taylor, facility
A packaging plant in Ireland is the latest to come into the cross-hairs of the people at Pfizer tasked with …
API imports in the EU: gauging the FMD’s impact
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing API, EMA, FMD, Taylor, manufacturing, supply chain
The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …
Lilly plans $700m insulin plant expansion programme
November 18, 2013Manufacturing and Production Taylor, lilly, manufacturing
Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …
Green light at Merck facility boosts varicella vaccine supplies
September 9, 2013Manufacturing and Production Merck, Taylor, varicella
Prospects for Merck & Co’s vaccines for shingles and chickenpox have been lifted by approval of additional bulk manufacturing capacity …
ICH starts consultation on elemental impurities guidance
August 7, 2013Manufacturing and Production ICH, Q3D, Taylor, USP
The International Conference on Harmonization (ICH) has started the consultation period on its long-awaited guidance on elemental impurities, a couple …
Charting the course of pharma contract manufacturing
August 5, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taylor, contract manufacturing, pharma
It’s no secret that the pharmaceutical sector has been on a bumpy ride over the last few years.
FDA ‘lacks authority to oversee compounding pharmacies’
August 2, 2013Manufacturing and Production FDA, GAO, NECC, Taylor
The US Food and Drug Administration lacks the power to properly regulate compounding pharmacies, according to a new Government Accounting …
Pharma excipients ‘may affect gastrointestinal tract’, says study
July 31, 2013Manufacturing and Production Taylor, excipients
Excipients used in oral solid dosage forms are typically considered to be inert, but researchers in Japan have found they …
FDA issues draft guidance on contract manufacturing
June 3, 2013Manufacturing and Production FDA, GMP, Taylor
The US Food and Drug Administration FDA has published draft guidance on quality agreements between pharma companies and contract manufacturers. …
China sets February 2013 deadline for excipient regulations
August 14, 2012Manufacturing and Production China, IPEC, SFDA, Taylor
China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …
